Ayahuasca Retreats: The Role of Awe and Mystical Experiences in Well-Being

被引:0
作者
Maclean, Brant [1 ]
Wilson, Amy [1 ]
Allen, Andrew [1 ]
Schaffer, Vikki [2 ]
Kannis-Dymand, Lee [1 ]
机构
[1] Univ Sunshine Coast, Sch Hlth, Discipline Psychol, 90 Sippy Downs Dr, Sunshine Coast, Qld 4556, Australia
[2] Univ Sunshine Coast, Sch Business & Creat Ind, Sunshine Coast, Australia
关键词
Awe; mystical experiences; psychedelics; well-being; ayahuasca retreats; DEPRESSION; DECREASES; INCREASES; SELF;
D O I
10.1080/02791072.2025.2491378
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Research on the positive psychological effects of psychedelics has surged since the early 2000s, particularly regarding increased well-being. Studies have demonstrated how psychedelic-occasioned mystical experiences play a key role in their positive effects, which has prompted an interest in the emotion of awe in the psychedelic context due to its similar phenomenology and associated benefits. This study examined 60 individuals following their visitation to at least one ayahuasca retreat in a country where ayahuasca use was legal or retreats are approved to use ayahuasca, hypothesizing that not only high levels of awe but mystical experiences characterized by high levels of awe would be significantly associated with higher well-being. Neither hypothesis was supported: higher levels of mystical experience with lower perceived vastness, a facet of awe, was significantly associated with higher well-being, possibly highlighting the synergistic relationship between mystical experiences and perceived vastness on well-being. The study has implications for future research, particularly in terms of understanding how the perceived vastness of a person's psychedelic experience may be modulated to mitigate distress and foster well-being.
引用
收藏
页数:11
相关论文
共 58 条
  • [1] Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug Effects
    Aday, Jacob S.
    Davis, Alan K.
    Mitzkovitz, Cayla M.
    Bloesch, Emily K.
    Davoli, Christopher C.
    [J]. ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2021, 4 (02) : 424 - 435
  • [2] Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer
    Agin-Liebes, Gabrielle, I
    Malone, Tara
    Yalch, Matthew M.
    Mennenga, Sarah E.
    Ponte, K. Linnae
    Guss, Jeffrey
    Bossis, Anthony P.
    Grigsby, Jim
    Fischer, Stacy
    Ross, Stephen
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2020, 34 (02) : 155 - 166
  • [3] Awe, Daily Stress, and Elevated Life Satisfaction
    Bai, Yang
    Ocampo, Joseph
    Jin, Gening
    Chen, Serena
    Benet-Martinez, Veronica
    Monroy, Maria
    Anderson, Craig
    Keltner, Dacher
    [J]. JOURNAL OF PERSONALITY AND SOCIAL PSYCHOLOGY, 2021, 120 (04) : 837 - 860
  • [4] Barrett FS, 2018, CURR TOP BEHAV NEURO, V36, P393, DOI 10.1007/7854_2017_474
  • [5] Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin
    Barrett, Frederick S.
    Johnson, Matthew W.
    Griffiths, Roland R.
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2015, 29 (11) : 1182 - 1190
  • [6] Measuring well-being rather than the absence of distress symptoms: A comparison of the SF-36 mental health subscale and the WHO-Five well-being scale
    Bech, P
    Olsen, LR
    Kjoller, M
    Rasmussen, NK
    [J]. INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH, 2003, 12 (02) : 85 - 91
  • [7] Wondering Awe as a Perceptive Aspect of Spirituality and Its Relation to Indicators of Wellbeing: Frequency of Perception and Underlying Triggers
    Buessing, Arndt
    [J]. FRONTIERS IN PSYCHOLOGY, 2021, 12
  • [8] Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan
    Carbonaro, Theresa M.
    Johnson, Matthew W.
    Griffiths, Roland R.
    [J]. PSYCHOPHARMACOLOGY, 2020, 237 (08) : 2293 - 2304
  • [9] Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
    Carhart-Harris, R. L.
    Bolstridge, M.
    Day, C. M. J.
    Rucker, J.
    Watts, R.
    Erritzoe, D. E.
    Kaelen, M.
    Giribaldi, B.
    Bloomfield, M.
    Pilling, S.
    Rickard, J. A.
    Forbes, B.
    Feilding, A.
    Taylor, D.
    Curran, H. V.
    Nutt, D. J.
    [J]. PSYCHOPHARMACOLOGY, 2018, 235 (02) : 399 - 408
  • [10] Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms
    Carhart-Harris, Robin L.
    Roseman, Leor
    Bolstridge, Mark
    Demetriou, Lysia
    Pannekoek, J. Nienke
    Wall, Matthew B.
    Tanner, Mark
    Kaelen, Mendel
    McGonigle, John
    Murphy, Kevin
    Leech, Robert
    Curran, H. Valerie
    Nutt, David J.
    [J]. SCIENTIFIC REPORTS, 2017, 7